To provide monitoring services for one (1) phase III clinical trial, A5300B/phoenix

Ended Awarded Last action

Contract number
75N93019F00131
Awardee
Awarding agency
Obligated
$5,696,077

Award facts

Opportunity
  • NIAIDNIHAO2015025 Solicitation number
Contract value 100% obligated
$5,696,076.64 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Cape Fear, NC 28401, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00010 · To administrate DE-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 -$62,448
Exercise an Option P00009 $892,055
Other Administrative Action P00008 $0
Exercise an Option P00007 $471,393
Exercise an Option P00006 · Daids onsite monitoring for 1 phase III study: A5300B/phoenix $929,916
Exercise an Option P00005 $903,544
Exercise an Option P00004 $877,923
Exercise an Option P00003 $853,039
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $830,654
Show all 11

About this award

The National Institute of Allergy and Infectious Diseases issued a delivery order to PPD Development LP on April 15, 2019, with a ceiling value of $5,696,076.64, to provide monitoring services for the A5300B/PHOENIX Phase III clinical trial and to administrate de-obligation of expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) by September 30, 2026. The order is issued under the NIAID/DCR Technical and Administrative Management Services parent IDIQ.

Place of performance is Cape Fear, NC. The ultimate completion date is December 14, 2025. This is a cost-plus-fixed-fee delivery order with no set-aside.

SCI reporting shows invoiced labor across six fiscal years. FY2025 (most recent) reflects $1.1 million invoiced with 6.0 FTEs and self-performed work. FY2024 invoiced $790 thousand across 4.6 FTEs and 9,493 contractor hours at a derived rate of $83.18 per hour. The trend from FY2021 through FY2024 shows declining hourly rates (from $88.82 to $83.18 per hour), with FY2025 marking a step-up in both dollar invoicing and FTE count. PPD self-performed all reported hours in FY2025 with no subcontractors engaged.

Quick answers

Who was awarded contract 75N93019F00131?

75N93019F00131 was awarded to PPD Development LP by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 15, 2019.

How much is contract 75N93019F00131 worth?

The government has obligated $5,696,077 on 75N93019F00131.

Is contract 75N93019F00131 an order under another contract?

Yes. 75N93019F00131 is a delivery order under HHSN272201700002I, an indefinite delivery contract, on NIAID/DCR Technical and Administrative Management Services.

Was contract 75N93019F00131 competed?

The extent of competition for 75N93019F00131 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award